| Full List of Protein(s) Regulating This Metabolite |
| Amino acid/auxin permease (AAAP) |
| Solute carrier family 38 member 3 (SLC38A3) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
| Detailed Information |
Protein Info
click to show the details of this protein
|
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
| Introduced Variation |
Knockout of Slc38a3 |
| Induced Change |
Cysteine concentration: increase |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Healthy individual
|
| Details |
It is reported that knockout of Slc38a3 leads to the increase of cysteine levels compared with control group. |
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
| Introduced Variation |
Knockout of SLC38A3 |
| Induced Change |
Cysteine concentration: increase |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Healthy individual
|
| Details |
It is reported that knockout of SLC38A3 leads to the increase of cysteine levels compared with control group. |
| Dicarboxylate/amino acid:cation symporter (DAACS) |
| Excitatory amino acid transporter 3 (SLC1A1) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
| Detailed Information |
Protein Info
click to show the details of this protein
|
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
| Introduced Variation |
Mutation (p.I395del) of SLC1A1 |
| Induced Change |
Cysteine concentration: decrease |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Nephropathic cystinosis [ICD-11: 5C60]
|
| Details |
It is reported that mutation (p.I395del) of SLC1A1 leads to the decrease of cysteine levels compared with control group. |
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
| Introduced Variation |
Mutation (p.R445W) of SLC1A1 |
| Induced Change |
Cysteine concentration: decrease |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Nephropathic cystinosis [ICD-11: 5C60]
|
| Details |
It is reported that mutation (p.R445W) of SLC1A1 leads to the decrease of cysteine levels compared with control group. |
| Neutral amino acid transporter A (SLC1A4) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Protein Info
click to show the details of this protein
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
| Introduced Variation |
Overexpression of SLC1A4 |
| Induced Change |
Cysteine concentration: increase |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Healthy individual
|
| Details |
It is reported that overexpression of SLC1A4 leads to the increase of cysteine levels compared with control group. |
| GPCR rhodopsin (GPCR-1) |
| Adrenergic receptor beta-3 (ADRB3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Protein Info
click to show the details of this protein
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[5] |
| Introduced Variation |
Agonist (CL-316,243) of Adrb3 |
| Induced Change |
Cysteine concentration: increase |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Healthy individual
|
| Details |
It is reported that agonist of ADRB3 leads to the increase of cysteine levels compared with control group. |
| GPCR secretin (GPCR-2) |
| Glucagon receptor (GCGR) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Protein Info
click to show the details of this protein
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[6] |
| Introduced Variation |
Knockout of Gcgr |
| Induced Change |
Cysteine concentration: increase (FC = 2.7) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Type 2 diabetes mellitus [ICD-11: 5A11]
|
| Details |
It is reported that knockout of GCGR leads to the increase of cysteine levels compared with control group. |
| Hydrolases (EC 3) |
| Alpha-N-acetylglucosaminidase (NAGLU) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Protein Info
click to show the details of this protein
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
| Introduced Variation |
Knockout of Naglu |
| Induced Change |
Cysteine concentration: decrease |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Lysosomal storage diseases [ICD-11: 5C56]
|
| Details |
It is reported that knockout of Naglu leads to the decrease of cysteine levels compared with control group. |
| Sulfatase sulf-1 (SULF1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Protein Info
click to show the details of this protein
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[8] |
| Introduced Variation |
Knockdown (shRNA) of SULF1 |
| Induced Change |
Cysteine concentration: increase (FC = 8.91 - 10.32) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Ovarian cancer [ICD-11: 2C73]
|
| Details |
It is reported that knockdown of SULF1 leads to the increase of cysteine levels compared with control group. |
| Oxidoreductases (EC 1) |
| L-2-hydroxyglutarate dehydrogenase (L2HGDH) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Protein Info
click to show the details of this protein
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
| Introduced Variation |
Mutation (Nonsense mutations or missense mutations) of L2hgdh |
| Induced Change |
Cysteine concentration: increase |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Melanoma [ICD-11: 2C30]
|
| Details |
It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of cysteine levels compared with control group. |
| Transcription factor (TF) |
| Myc proto-oncogene protein (MYC) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Protein Info
click to show the details of this protein
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[10] |
| Introduced Variation |
Knockdown (siRNA) of MYC |
| Induced Change |
Cysteine concentration: decrease |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colorectal cancer [ICD-11: 2B91]
|
| Details |
It is reported that knockdown of MYC leads to the decrease of cysteine levels compared with control group. |
|
|
|
|
|
|
|